Literature DB >> 15254224

Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6.

Toru Ogasawara1, Hiroshi Kawaguchi, Shigeki Jinno, Kazuto Hoshi, Keiji Itaka, Tsuyoshi Takato, Kozo Nakamura, Hiroto Okayama.   

Abstract

Because a temporal arrest in the G(1) phase of the cell cycle is thought to be a prerequisite for cell differentiation, we investigated cell cycle factors that critically influence the differentiation of mouse osteoblastic MC3T3-E1 cells induced by bone morphogenetic protein 2 (BMP-2), a potent inducer of osteoblast differentiation. Of the G(1) cell cycle factors examined, the expression of cyclin-dependent kinase 6 (Cdk6) was found to be strongly down-regulated by BMP-2/Smads signaling, mainly via transcriptional repression. The enforced expression of Cdk6 blocked BMP-2-induced osteoblast differentiation to various degrees, depending on the level of its overexpression. However, neither BMP-2 treatment nor Cdk6 overexpression significantly affected cell proliferation, suggesting that the inhibitory effect of Cdk6 on cell differentiation was exerted by a mechanism that is largely independent of its cell cycle regulation. These results indicate that Cdk6 is a critical regulator of BMP-2-induced osteoblast differentiation and that its Smads-mediated down-regulation is essential for efficient osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254224      PMCID: PMC444857          DOI: 10.1128/MCB.24.15.6560-6568.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.

Authors:  Y Yan; J Frisén; M H Lee; J Massagué; M Barbacid
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

2.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

3.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.

Authors:  P Zhang; N J Liégeois; C Wong; M Finegold; H Hou; J C Thompson; A Silverman; J W Harper; R A DePinho; S J Elledge
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

Review 4.  Tumor suppressor genes.

Authors:  P W Hinds; R A Weinberg
Journal:  Curr Opin Genet Dev       Date:  1994-02       Impact factor: 5.578

Review 5.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

6.  Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.

Authors:  Qiuhong Chen; Jie Lin; Shigeki Jinno; Hiroto Okayama
Journal:  Oncogene       Date:  2003-02-20       Impact factor: 9.867

7.  CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells.

Authors:  Igor Matushansky; Farshid Radparvar; Arthur I Skoultchi
Journal:  Oncogene       Date:  2003-07-03       Impact factor: 9.867

8.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

9.  Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.

Authors:  C Deng; P Zhang; J W Harper; S J Elledge; P Leder
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

10.  A family of human cdc2-related protein kinases.

Authors:  M Meyerson; G H Enders; C L Wu; L K Su; C Gorka; C Nelson; E Harlow; L H Tsai
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  46 in total

Review 1.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

Review 2.  Targeting CDK6 in cancer: State of the art and new insights.

Authors:  Solomon Tadesse; Mingfeng Yu; Malika Kumarasiri; Bich Thuy Le; Shudong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation.

Authors:  Michael Woods; Rima Pant; Sanjay M Mallya
Journal:  Int J Oncol       Date:  2010-12       Impact factor: 5.650

4.  Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.

Authors:  Xian Wang; Christopher Sistrunk; Marcelo L Rodriguez-Puebla
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  Synthesis and characterization of osteoinductive visible light-activated adhesive composites with antimicrobial properties.

Authors:  Amirhossein Moghanian; Roberto Portillo-Lara; Ehsan Shirzaei Sani; Hailey Konisky; Seyed Hossein Bassir; Nasim Annabi
Journal:  J Tissue Eng Regen Med       Date:  2019-12-18       Impact factor: 3.963

6.  Gossypin induces G2/M arrest in human malignant glioma U251 cells by the activation of Chk1/Cdc25C pathway.

Authors:  Lei Shi; Jian Chen; Yin-yi Wang; Guan Sun; Jing-ning Liu; Jun-xia Zhang; Wei Yan; Chun-fa Qian; Ning Liu; Zhen Fu; Yong-ping You; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2011-10-09       Impact factor: 5.046

7.  Expression of cdk6 in head and neck squamous cell carcinoma.

Authors:  Sopee Poomsawat; Sirima Sanguansin; Jirapa Punyasingh; Paisarn Vejchapipat; Phaibul Punyarit
Journal:  Clin Oral Investig       Date:  2015-05-01       Impact factor: 3.573

8.  Distinct subcellular distribution of cyclin dependent kinase 6.

Authors:  Dawn M Kohrt; Jennifer I Crary; Vasilena Gocheva; Philip W Hinds; Martha J Grossel
Journal:  Cell Cycle       Date:  2009-09-14       Impact factor: 4.534

9.  microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.

Authors:  Zhenze Zhao; Xiuye Ma; Derek Sung; Monica Li; Adam Kosti; Gregory Lin; Yidong Chen; Alexander Pertsemlidis; Tzu-Hung Hsiao; Liqin Du
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

10.  PU.1 directly regulates cdk6 gene expression, linking the cell proliferation and differentiation programs in erythroid cells.

Authors:  Kevin S Choe; Olga Ujhelly; Sandeep N Wontakal; Arthur I Skoultchi
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.